ROCker Models for Reliable Detection and Typing of Short-Read Sequences Carrying β-Lactamase Genes.
ROCker models
high F1 score
short reads
β-lactamases
Journal
mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
pubmed:
1
6
2022
medline:
1
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Identification of genes encoding β-lactamases (BLs) from short-read sequences remains challenging due to the high frequency of shared amino acid functional domains and motifs in proteins encoded by BL genes and related non-BL gene sequences. Divergent BL homologs can be frequently missed during similarity searches, which has important practical consequences for monitoring antibiotic resistance. To address this limitation, we built ROCker models that targeted broad classes (e.g., class A, B, C, and D) and individual families (e.g., TEM) of BLs and challenged them with mock 150-bp- and 250-bp-read data sets of known composition. ROCker identifies most-discriminant bit score thresholds in sliding windows along the sequence of the target protein sequence and hence can account for nondiscriminative domains shared by unrelated proteins. BL ROCker models showed a 0% false-positive rate (FPR), a 0% to 4% false-negative rate (FNR), and an up-to-50-fold-higher F1 score [2 × precision × recall/(precision + recall)] compared to alternative methods, such as similarity searches using BLASTx with various e-value thresholds and BL hidden Markov models, or tools like DeepARG, ShortBRED, and AMRFinder. The ROCker models and the underlying protein sequence reference data sets and phylogenetic trees for read placement are freely available through http://enve-omics.ce.gatech.edu/data/rocker-bla. Application of these BL ROCker models to metagenomics, metatranscriptomics, and high-throughput PCR gene amplicon data should facilitate the reliable detection and quantification of BL variants encoded by environmental or clinical isolates and microbiomes and more accurate assessment of the associated public health risk, compared to the current practice.
Identifiants
pubmed: 35638728
doi: 10.1128/msystems.01281-21
pmc: PMC9238382
doi:
Substances chimiques
beta-Lactamases
EC 3.5.2.6
Anti-Bacterial Agents
0
beta-Lactams
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e0128121Références
Bioinformatics. 2018 Jul 1;34(13):2263-2270
pubmed: 29408954
Nat Rev Microbiol. 2010 Apr;8(4):251-9
pubmed: 20190823
Nucleic Acids Res. 2012 Jul;40(12):e94
pubmed: 22434876
Lancet Infect Dis. 2008 Mar;8(3):159-66
pubmed: 18291338
Microbiome. 2018 Jan 15;6(1):11
pubmed: 29335005
Antimicrob Agents Chemother. 2014;58(2):767-81
pubmed: 24247131
BMC Bioinformatics. 2006 Nov 09;7:495
pubmed: 17094801
Nucleic Acids Res. 2011 Aug;39(14):e91
pubmed: 21586583
Biochem J. 1991 May 15;276 ( Pt 1):269-70
pubmed: 2039479
Nat Methods. 2015 Jan;12(1):59-60
pubmed: 25402007
Brief Bioinform. 2012 Nov;13(6):669-81
pubmed: 22962338
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
S Afr J Infect Dis. 2019 Aug 07;34(1):114
pubmed: 34485454
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Sci Rep. 2017 Feb 24;7:43232
pubmed: 28233789
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
Front Microbiol. 2013 Oct 01;4:291
pubmed: 24101916
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Lancet Infect Dis. 2013 Feb;13(2):155-65
pubmed: 23347633
Ann N Y Acad Sci. 2017 Jan;1388(1):78-91
pubmed: 27875856
Antimicrob Agents Chemother. 2004 Jul;48(7):2400-8
pubmed: 15215087
Mol Cell Probes. 2009 Jun-Aug;23(3-4):195-200
pubmed: 19496249
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Antibiotics (Basel). 2014 Jul 1;3(3):285-316
pubmed: 25364574
Microbiome. 2018 Feb 01;6(1):23
pubmed: 29391044
BMC Infect Dis. 2009 Jan 22;9:7
pubmed: 19161622
Nat Microbiol. 2017 Jan 30;2:16270
pubmed: 28134918
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
BMC Microbiol. 2017 Apr 27;17(1):101
pubmed: 28449650
Microbiome. 2019 Apr 1;7(1):52
pubmed: 30935407
Nucleic Acids Res. 2014 Oct 29;42(19):e145
pubmed: 25260589
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Nucleic Acids Res. 2013 Jul;41(12):e121
pubmed: 23598997
Trends Genet. 2000 Jun;16(6):276-7
pubmed: 10827456
Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33
pubmed: 7574506
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Protein Eng. 1999 Feb;12(2):85-94
pubmed: 10195279
PLoS Comput Biol. 2015 Dec 18;11(12):e1004557
pubmed: 26682918
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33
pubmed: 20805405
Nucleic Acids Res. 2009 Jan;37(Database issue):D443-7
pubmed: 18832362
Antimicrob Agents Chemother. 2005 Aug;49(8):3453-62
pubmed: 16048960
Genome Res. 2007 Mar;17(3):377-86
pubmed: 17255551
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Appl Microbiol Biotechnol. 2016 Nov;100(21):9343-9353
pubmed: 27522197
Chembiochem. 2016 Nov 3;17(21):2093-2098
pubmed: 27562499
Bioinformatics. 2016 Aug 1;32(15):2346-51
pubmed: 27153579
BMC Genomics. 2009 Aug 21;10:390
pubmed: 19698099
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Nucleic Acids Res. 2017 Feb 17;45(3):e14
pubmed: 28180325